Overview
Nasir earned his medical degree from the University of Texas Health Science Center at San Antonio where he ranked first in his class. He was honored as a recipient of the Lange Medical Publications Award. Following his internship at Baylor College of Medicine, he completed his residency at the University of California, San Francisco, a well known center for research and clinical practice.Dr. Nasir pursued post-graduate work as a Fellow in Vitreoretinal Research and Clinical Studies at Duke University, where he also trained with Dr. Robert Machemer, who invented the first vitrectomy machine and is considered the father of modern vitreous surgery. He was chosen as a Heed Ophthalmic Foundation Fellow and was the recipient of a grant for the Research to Prevent Blindness Foundation.Dr. Nasir is a diplomate of the American Board of Ophthalmology, a member of the American Society of Retina Specialists, the American Academy of Ophthamology, and the Association for Research in Vision and Ophthalmology. Dr. Nasir is a co-founder of the California Retina Research Foundation and has been the principal investigator or coinvestigator for numerous national clinical trials at California Retina Consultants. His research interests include choroidal neovascularization associated with age-related macular degeneration, as well as adjunctive pharmacological therapies used in the surgeries for diabetic retinopathy and proliferative vitreoretinopathy. The results of his work have been reported in distinguished journals such as the American Journal of Ophthalmology, Ophthalmology, the British Journal of Ophthalmology and Retina. He and his colleagues at California Retina Consultants published the first series of patients treated with Avastin for age-related macular degeneration and subsequent peer reviewed articles for the use of Avastin for other retinal diseases. Dr. Nasir is a representative and a past vice president of the California Academy of Ophthalmology as well as a member of S.E.E. International and with his colleagues regularly train ophthalmologists from developing countries.Clinically, Dr. Nasir is particularly interested in age-related macular degeneration, diabetic retinopathy, complex retinal detachments and macular surgery. His research and surgical foci are balanced with a keen concern for patient care.As vitreoretinal specialists, we provide comprehensive medical and surgical treatment for all disorders of the retina, macula and vitreous. We focus on the diagnosis, prevention and treatment of these conditions. Many abnormalities of the retina and vitreous may cause visual loss. These disorders include macular degeneration, diabetic retinopathy, retinal detachment, macular holes, macular edema and epiretinal membranes. Our practice has multiple locations throughout Central California to serve our patients.
Dr. Nasir is rated as an Advanced provider by MediFind in the treatment of Age-Related Macular Degeneration (ARMD). His top areas of expertise are Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Retinal Vein Occlusion, and Retinal Artery Occlusion.
His clinical research consists of co-authoring 2 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of Age-Related Macular Degeneration (ARMD).
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER MEDICARE
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MEDICARE MAPD
- HMO
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
1801 N Solar Dr, Ste 145, Oxnard, CA 93030
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Giulia Corradetti is an Ophthalmologist in Los Angeles, California. Dr. Corradetti has been practicing medicine for over 16 years and is rated as a Distinguished provider by MediFind in the treatment of Age-Related Macular Degeneration (ARMD). Her top areas of expertise are Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Geographic Atrophy, Adult-Onset Vitelliform Macular Dystrophy (AVMD), and Vitrectomy.
Dante J. Pieramici, MD Private Practice
Dr. Dante J. Pieramici graduated with honors from the Johns Hopkins University School of Medicine and completed Ophthalmology Residency at the Wilmer Eye Institute. He receive vitreoretinal fellowship training at the Emory Eye Center in Atlanta Georgia. Dr. Pieramici has held full-time academic positions at the Yale University Eye Center and the Wilmer Eye Institute, where he served as the Assistant Chief of Service and Director of Ocular Trauma. Currently he is the Codirector of the California Retina Research Foundation, a partner of the California Retina Consultants, and Assistant Clinical Professor of Ophthalmology at the Doheny Eye Center in Southern California. Dr. Pieramici has published over 100 articles, 16 book chapters, and has edited 3 books on retinal diseases. He lectures nationally and internationally on retinal diseases and ocular trauma.Dr. Pieramici’s research interests have been varied, and include clinical and basic science projects aimed at better understanding of the underlying pathophysiology of ocular diseases, so as to improve treatments for patients with age-related macular degeneration, diabetic retinopathy, retinal vascular diseases, and severe ocular injuries. He has been a clinical investigator, principal investigator, or reading center investigator in numerous NIH and pharmaceutical company sponsored clinical trials. Dr Pieramici has helped in the development of new surgical techniques including limited macular translocation and 25-gauge (small incision) vitrectomy surgery. Currently he is involved in the development of new drug delivery techniques for various retinal vascular diseases.Dr. Pieramici has received the Achievement Award from the American Academy of Ophthalmology and Honor Award from the American Society of Retinal Specialists. He is a member of the American Academy of Ophthalmology, the Retina Society, the Macula Society, the American Society of Retinal Specialists, the Association for Research in Vision and Ophthalmology, the American Society of Ocular Trauma where he serves as Vice President, and the Pan-American Ophthalmologic Society amongst others. Dr Pieramici is a member of S.E.E International and regularly trains international ophthalmologists from undeserved areas.As vitreoretinal specialists, we provide comprehensive medical and surgical treatment for all disorders of the retina, macula and vitreous. We focus on the diagnosis, prevention and treatment of these conditions. Many abnormalities of the retina and vitreous may cause visual loss. These disorders include macular degeneration, diabetic retinopathy, retinal detachment, macular holes, macular edema and epiretinal membranes. Our practice has multiple locations throughout Central California to serve our patients. Dr. Pieramici is rated as a Distinguished provider by MediFind in the treatment of Age-Related Macular Degeneration (ARMD). His top areas of expertise are Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Diabetic Macular Edema (DME), Diabetic Retinopathy, and Vitrectomy.
USC Care Medical Group Inc
Andrew Moshfeghi is an Ophthalmologist in Los Angeles, California. Dr. Moshfeghi is rated as a Distinguished provider by MediFind in the treatment of Age-Related Macular Degeneration (ARMD). His top areas of expertise are Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Diabetic Retinopathy, Vitrectomy, and Trabeculectomy.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Age-Related Macular Degeneration (ARMD)
- Diabetic RetinopathyDr. Nasir isAdvanced. Learn about Diabetic Retinopathy.
- EndophthalmitisDr. Nasir isAdvanced. Learn about Endophthalmitis.
- Late-Onset Retinal DegenerationDr. Nasir isAdvanced. Learn about Late-Onset Retinal Degeneration.
- Retinal Artery OcclusionDr. Nasir isAdvanced. Learn about Retinal Artery Occlusion.
- Retinal DetachmentDr. Nasir isAdvanced. Learn about Retinal Detachment.
- Experienced
- Brown SyndromeDr. Nasir isExperienced. Learn about Brown Syndrome.
- Central Serous ChorioretinopathyDr. Nasir isExperienced. Learn about Central Serous Chorioretinopathy.
- Coats DiseaseDr. Nasir isExperienced. Learn about Coats Disease.
- Familial Exudative VitreoretinopathyDr. Nasir isExperienced. Learn about Familial Exudative Vitreoretinopathy.
- Geographic AtrophyDr. Nasir isExperienced. Learn about Geographic Atrophy.
- Retinal Vasculopathy with Cerebral Leukodystrophy